ArticleDatabase : the journal of biological databases and curation2025
HCoVDB: a comprehensive database encompassing viral genomes, drug targets, and therapeutics of human coronaviruses.
Article in Database : the journal of biological databases and curation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Over the past few decades, coronavirus outbreaks have been reported globally. To date, seven human coronaviruses have been identified, among which only SARS-CoV-2 has been extensively studied, resulting in the development of several approved antiviral drugs. To effectively combat both current and emerging coronaviruses, there is an urgent need for a comprehensive database that consolidates information on all known human coronaviruses and their potential antiviral compounds. In response, we present HCoVDB-a comprehensive database that integrates genomic data, viral proteins, and antiviral agents with demonstrated in vitro or in vivo activity against the seven human coronaviruses. Compared to existing coronavirus databases, HCoVDB offers three distinctive features: (i) a curated collection and annotation of over 4 million genomic sequences from all seven human coronaviruses, including key amino acid substitutions that influence viral fitness, drug resistance, and immune evasion; (ii) a protein-drug docking platform for predicting the binding interactions of antiviral agents with demonstrated activity; and (iii) an extensive compilation of antiviral agents, along with their chemical properties and antiviral efficacy profiles (IC50, EC50, or CC50) as reported in the literature. Overall, HCoVDB provides a valuable resource for tracking the evolutionary dynamics of coronaviruses and accelerating the development of broad-spectrum antiviral agents against coronavirus infections in the future. Database URL: http://hcovdb.denglab.org/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.